Lingzhi Chen
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats" [Life Sci. 224 (2019) 177-186].
Journal: Life sciences
Published: April 05, 2022
Inhibition of prostaglandin E2 receptor 4 by lnc000908 to promote the endothelial-mesenchymal transition participation in cardiac remodelling.
Journal: Journal of cellular and molecular medicine
Published: March 02, 2019
Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats.
Journal: Life sciences
Published: December 14, 2018
Serum relaxin level predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
Journal: Heart and vessels
Published: November 26, 2018
The Distribution of Syphilis Among Inpatients in Wenzhou, China: A Hospital Based Study.
Journal: Jundishapur journal of microbiology
Published: May 27, 2015
Protective Effect of Spironolactone on Endothelial-to-Mesenchymal Transition in HUVECs via Notch Pathway.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: March 23, 2015
Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats.
Journal: Molecules (Basel, Switzerland)
Published: July 22, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026